Abeona Therapeutics, Inc. (ABEO)
5.325
+0.20
(+4.00%)
USD |
NASDAQ |
May 20, 16:00
5.325
0.00 (0.00%)
After-Hours: 20:00
Abeona Therapeutics Market Cap : 303.50M for May 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Celldex Therapeutics, Inc. | 2.423B |
| Plus Therapeutics, Inc. | 43.92M |
| Perspective Therapeutics, Inc. | 431.09M |
| Myriad Genetics, Inc. | 359.85M |
| Atossa Therapeutics, Inc. | 42.02M |
Market Cap Related Metrics
| PE Ratio | 5.682 |
| PS Ratio | 21.29 |
| Price to Book Value | 2.094 |
| Price | 5.325 |
| Earnings Yield | 17.60% |
| Normalized PE Ratio | 6.105 |